I 
117TH CONGRESS 
1ST SESSION H. R. 3851 
To improve support for research and development of advanced pharmaceutical 
manufacturing techniques and workforce. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 11, 2021 
Ms. SPANBERGER (for herself, Mr. GONZALEZ of Ohio, Mr. MEIJER, Ms. 
ROSS, Mr. TONKO, and Mr. MCKINLEY) introduced the following bill; 
which was referred to the Committee on Science, Space, and Technology 
A BILL 
To improve support for research and development of ad-
vanced pharmaceutical manufacturing techniques and 
workforce. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Continuous Manufac-
4
turing Research Act of 2021’’. 
5
VerDate Sep 11 2014 
17:41 Jun 30, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3851.IH
H3851
lotter on DSK11XQN23PROD with BILLS
2 
•HR 3851 IH
SEC. 2. RESEARCH ON ADVANCED PHARMACEUTICAL MAN-
1
UFACTURING. 
2
Section 506(a) of the America COMPETES Reau-
3
thorization Act of 2010 (42 U.S.C. 1862p–1(a)) is amend-
4
ed— 
5
(1) in paragraph (5), by striking ‘‘and’’ at the 
6
end; 
7
(2) in paragraph (6), by striking the period at 
8
the end and inserting ‘‘; and’’; and 
9
(3) by adding at the end the following: 
10
‘‘(7) advanced pharmaceutical manufacturing 
11
fundamental and translational research, including— 
12
‘‘(A) continuous manufacturing of drugs 
13
and biological products; and 
14
‘‘(B) similar innovative monitoring and 
15
control techniques.’’. 
16
Æ 
VerDate Sep 11 2014 
17:41 Jun 30, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H3851.IH
H3851
lotter on DSK11XQN23PROD with BILLS
